Anavex Life Sciences Corp (AVXL)

[Gator328]

It’s a big milestone for the company but in terms of the share price, I’m not expecting even with great news that the stock goes parabolic to $40+ like many are predicting. If anything even with positive data, based on history the price may even initially drop if there are attack articles and hit pieces falsely claiming a failed trial.

The big event for me is FDA approval. The quality of the data will help me decide the odds of approval. The share price is irrelevant until then because approval is when the big pop happens.

We can have great data and still face headwinds from larger biotechs with political influence that don’t want Sigma1 to become the next big thing. I think good data will lead to approval but the path may still require more hurdles to clear such as AdComm.

Today is a big day for the company. It may not be a great day for the share price. Expect the shorts’ reaction to be negative and be pleased if something better happens. That’s how I maintain my sanity and rational thinking whenever Anavex releases data.